Harmony Biosciences Holdings, I

Historical 13F Holders

Symbol
HRMY
CUSIP
413197104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 413197104 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 11.3% 7/28/2026
Event 6/30/2026
Marshman Fund Trust II 13G/A 10.6% 2/10/2025
Event 12/31/2024
FMR LLC 13G/A
5.4% 2/5/2026
Event 12/31/2025
Vanguard Portfolio Management LLC 13G 5.1% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Valor IV Pharma Holdings, LLC 13G/A
3.2% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 18 426 k $8.17 M
2026 Q2 338 56.2 M $2.02 B
2026 Q1 322 56.0 M $1.56 B
2025 Q4 336 50.1 M $1.88 B
2025 Q3 315 47.6 M $1.31 B
2025 Q2 289 51.5 M $1.63 B
2025 Q1 284 50.3 M $1.67 B
2024 Q4 255 52.8 M $1.82 B
2024 Q3 244 50.4 M $2.01 B
2024 Q2 232 51.2 M $1.54 B
2024 Q1 218 50.8 M $1.71 B
2023 Q4 233 49.4 M $1.59 B
2023 Q3 218 49.6 M $1.62 B
2023 Q2 223 52.0 M $1.83 B
2023 Q1 230 51.5 M $1.68 B
2022 Q4 256 52.5 M $2.87 B
2022 Q3 213 52.2 M $2.31 B
2022 Q2 190 48.1 M $2.39 B
2022 Q1 188 46.1 M $2.26 B
2021 Q4 151 44.8 M $1.91 B
2021 Q3 103 30.9 M $1.19 B
2021 Q2 86 28.5 M $804 M
2021 Q1 59 27.8 M $918 M
2020 Q4 60 28.0 M $998 M
2020 Q3 45 28.5 M $941 M